United States - English - NLM (National Library of Medicine)

cardinal health - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 100 mg

United States - English - NLM (National Library of Medicine)

tya pharmaceuticals - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the significant risk of agranulocytosis and seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment . [see warnings and precautions (5.1, 5.4)] the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics . [see clinical studies (14.1)] clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to action

United States - English - NLM (National Library of Medicine)

jazz pharmaceuticals, inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 12.5 mg - fazaclo is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, fazaclo should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5) ]. the effectiveness of clozapine in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)]. fazaclo is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectiveness o

United States - English - NLM (National Library of Medicine)

hls therapeutics (usa), inc. - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 25 mg - clozaril is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. because of the risks of severe neutropenia and of seizure associated with its use, clozaril should be used only in patients who have failed to respond adequately to standard antipsychotic treatment [see warnings and precautions (5.1, 5.5)] . the effectiveness of clozaril in treatment-resistant schizophrenia was demonstrated in a 6-week, randomized, double-blind, active-controlled study comparing clozaril and chlorpromazine in patients who had failed other antipsychotics [see clinical studies (14.1)] . clozaril is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death. the effectiveness of c

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - clozapine 100 mg - tablet - 100 mg - clozapine 100 mg - clozapine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - clozapine 50 mg - tablet - 50 mg - clozapine 50 mg - clozapine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - clozapine 25 mg - tablet - 25 mg - clozapine 25 mg - clozapine

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

oethmaan biosims (pty) ltd - tablet - see ingredients - each tablet contains clozapine 25,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - clozapine, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: povidone; sodium propyl hydroxybenzoate; purified water; sodium methyl hydroxybenzoate; xanthan gum; glycerol; monobasic sodium phosphate dihydrate; sodium hydroxide; hydrochloric acid; sorbitol solution (70 per cent) (crystallising) - treatment with clopine is indicated only in people with treatment-resistant schizophrenia, ie. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Israel - English - Ministry of Health

taro international ltd, israel - clozapine - tablets - clozapine 25 mg - clozapine - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.suicidal behavior refers to actions by a patient that put him/herself at risk for death